Cargando…
Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
Background: Colorectal cancer (CRC) is the result of complex interactions between the tumor's molecular profile and metabolites produced by its microenvironment. Despite recent studies identifying CRC molecular subtypes, a metabolite classification system is still lacking. We aimed to explore t...
Autores principales: | Long, Zhiping, Zhou, Junde, Xie, Kun, Wu, Zhen, Yin, Huihui, Daria, Volontovich, Tian, Jingshen, Zhang, Nannan, Li, Liangliang, Zhao, Yashuang, Wang, Fan, Wang, Maoqing, Cui, Yunfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311671/ https://www.ncbi.nlm.nih.gov/pubmed/32626659 http://dx.doi.org/10.3389/fonc.2020.00981 |
Ejemplares similares
-
Differential Metabolic Alterations and Biomarkers Between Gastric Cancer and Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Tian, Jingshen, et al.
Publicado: (2020) -
High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease
por: Xie, Kun, et al.
Publicado: (2021) -
Multiple exposure to environmental factors and variations in CYP27B1 and the microRNA‐binding site of IL‐13 are associated with breast cancer risk
por: Zhang, Nannan, et al.
Publicado: (2019) -
Discovery of plasma biomarkers for colorectal cancer diagnosis via untargeted and targeted quantitative metabolomics
por: Wang, Maoqing, et al.
Publicado: (2022) -
Dietary factors and microRNA-binding site polymorphisms in the IL13 gene: risk and prognosis analysis of colorectal cancer
por: Yu, Yanming, et al.
Publicado: (2017)